The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pembrolizumab treatment of advanced cervical cancer: Updated results from the phase 2 KEYNOTE-158 study.
 
Hyun Cheol Chung
Consulting or Advisory Role - Bristol-Myers Squibb; Celltrion; Lilly; Merck Serono; MSD; Quintiles; Taiho Pharmaceutical
Speakers' Bureau - Foundation medicine; Lilly; Merck Serono
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Merck Serono; MSD; Taiho Pharmaceutical
 
Jan H. M. Schellens
Employment - Modra Pharmaceuticals
Stock and Other Ownership Interests - Modra Pharmaceuticals
Research Funding - Dutch Cancer Society (Inst)
 
Jean-Pierre Delord
No Relationships to Disclose
 
Ruth Perets
Employment - Musli Thyropeutics
Honoraria - BMS Brazil
 
Antoine Italiano
Consulting or Advisory Role - Bayer; Eisai; Epizyme; Lilly; Novartis; PharmaMar
Research Funding - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis
 
Ronnie Shapira-Frommer
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Roche
Consulting or Advisory Role - Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
Lyudmila Manzuk
No Relationships to Disclose
 
Sarina Anne Piha-Paul
Consulting or Advisory Role - Genentech
Research Funding - Abbvie; Bayer; BlueLink; Curis; Five Prime Therapeutics; GlaxoSmithKline; Helix BioPharma; Incyte; MedImmune; Medivation; Merck Sharp & Dohme; Novartis; Pfizer; Pieris Pharmaceuticals; Principa Biopharma; Puma Biotechnology; Tesaro; XuanZhu
 
Jiangdian Wang
Employment - Merck
 
Susan Zeigenfuss
Employment - Merck
 
Scott K. Pruitt
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Aurelien Marabelle
Honoraria - AMGEN; AstraZeneca/MedImmune; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Merck Serono; Roche/Genentech; Sanofi; SERVIER
Consulting or Advisory Role - AMGEN; Eisai; etherna; GENMAB; GENTICEL; GlaxoSmithKline; Kyowa Hakko Kirin; Lytix Biopharma; Merck Serono; NEKTAR; NOVARTIS; Pfizer; Pierre Fabre; RIGONTEC; Symphony Evolution
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); MERUS (Inst); Transgene (Inst)
Patents, Royalties, Other Intellectual Property - monoclonal antibodies against CD81 (Stanford University)
Other Relationship - PEGASCY